Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications

Area of Science:

• Endocrinology
• Clinical Chemistry
• Assay Development

Background:

• Thyrotropin (TSH) is a key regulator of thyroid function.
• Accurate TSH measurement is crucial for diagnosing and managing thyroid disorders.
• Existing assays may lack the sensitivity required for subtle thyroid dysfunction or treatment monitoring.

Purpose of the Study:

• To enhance the analytical sensitivity of a two-site immunoradiometric assay for serum TSH.
• To evaluate the clinical utility of the improved TSH assay in various thyroid conditions.
• To assess the assay's potential to replace traditional diagnostic methods like TRH stimulation tests.

Main Methods:

• Modification of a two-site immunoradiometric assay to improve analytical sensitivity.
• Measurement of serum TSH, free T4 (FT4), and T3 in healthy individuals, patients with thyroid disorders, and those on treatment.
• Correlation of baseline TSH with thyrotropin releasing hormone (TRH) stimulation test results.

Main Results:

• Achieved a detection limit of approximately 0.1 microU/ml and a lower limit of quantification of approximately 0.4 microU/ml.
• Identified suppressed TSH (<0.3 microU/ml) in 97% of hyperthyroid patients and in some patients with suspected mild hyperthyroidism.
• Demonstrated TSH suppression in patients on antithyroid drugs and identified suboptimal L-T4 dosage in thyroid cancer patients.
• Observed a strong correlation (r=0.85) between baseline TSH and peak TSH post-TRH stimulation.

Conclusions:

• Sensitive TSH measurements can reliably diagnose hyperthyroidism, even in equivocal cases.
• The improved assay can potentially replace most TRH-stimulation tests.
• Sensitive TSH assays are valuable for optimizing L-T4 suppression therapy in post-thyroidectomy thyroid cancer patients.